STOCK TITAN

AM Best Affirms Credit Ratings of Globe Life Inc. and Its Subsidiaries

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)
Tags
Rhea-AI Summary
AM Best affirms the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of Globe Life Inc.'s key life/health subsidiaries. The ratings reflect Globe Life's strong balance sheet, very strong operating performance, and favorable business profile. Globe Life's year-end capital & surplus increased, but was hampered by dividend payments and share repurchases. Earnings rebounded in 2022 due to higher premium volumes and reduced mortality experience. Globe Life's geographically diversified product offering and expansion of its ERM program are positive factors. The ratings outlook is stable.
Positive
  • AM Best affirms the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of Globe Life Inc.'s key life/health subsidiaries. The ratings reflect Globe Life's strong balance sheet, very strong operating performance, and favorable business profile. Earnings rebounded in 2022 due to higher premium volumes and reduced mortality experience. Globe Life's geographically diversified product offering and expansion of its ERM program are positive factors.
Negative
  • None.

OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “a+” (Excellent) of the key life/health subsidiaries of Globe Life Inc. (Globe Life) (headquartered in McKinney, TX) [NYSE: GL]. Concurrently, AM Best has affirmed the Long-Term ICR of “bbb+” (Good) of Globe Life. AM Best also has affirmed the Short- and Long-Term Issue Credit Ratings (Short-Term IR; Long-Term IR) on the debt and the indicative Long-Term IRs on the securities of Globe Life. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of these companies and ratings.)

The ratings reflect Globe Life’s balance sheet strength, which AM Best assesses as strong, as well as its very strong operating performance, favorable business profile and appropriate enterprise risk management (ERM).

Globe Life’s risk-based capital is assessed within the strong category, as measured by Best’s Capital Adequacy Ratio (BCAR). On a statutory basis, year-end capital & surplus increased, but was hampered by continued dividend payments to Globe Life. Surplus growth was also slowed by the share repurchase program. Globe Life’s investment portfolio, which is managed on a consolidated basis, is primarily comprised of public, investment grade bonds with an increasing allocation to Schedule BA assets in the form of limited partnerships. Globe Life’s higher allocation to Class 2 bonds accounts for more than half of its bond portfolio, making Globe Life more susceptible to credit downgrades. Financial leverage and coverage ratios remain within tolerance for its current ratings.

Globe Life has consistently reported strong earnings and return on equity, steady premium income and favorable investment income, which supports the group’s operating performance assessment. In 2022, earnings rebounded from 2021, and are back to historical levels. This is mostly attributable to higher premium volumes and reduced mortality experience. The group’s health segment also contributed to positive earnings.

Globe Life is geographically diversified with a robust product offering that includes life and supplemental health insurance products for middle class and retired individuals. Globe Life’s products are offered through agents and direct-to-consumer. Most agents are exclusive to Globe Life and sell relatively low risk products. Additionally, Globe Life continues to expand its formalized ERM program, and AM Best believes that the group’s ERM program is appropriate given its risk profile.

The FSR of A (Excellent) and the Long-Term ICRs of “a+” (Excellent) have been affirmed with stable outlooks for the following life/health subsidiaries of Globe Life Inc.:

  • American Income Life Insurance Company
  • Globe Life and Accident Insurance Company
  • Liberty National Life Insurance Company
  • United American Insurance Company
  • Globe Life Insurance Company of New York
  • National Income Life Insurance Company
  • Family Heritage Life Insurance Company

The following Short-Term IR has been affirmed:

Globe Life Inc. —
— AMB-1 (Outstanding) on commercial paper

The following Long-Term IRs have been affirmed with stable outlooks:

Globe Life Inc. —
— “bbb+” (Good) on $550 million 4.55% senior unsecured notes, due 2028
— “bbb+” (Good) on $400 million 2.15% senior unsecured, due 2030
— “bbb-” (Good) on $325 million 4.25% junior subordinated debentures, due 2061

The following indicative Long-Term IRs available under the shelf registration have been affirmed with stable outlooks:

Globe Life Inc. —
— “bbb+” (Good) on senior unsecured debt
— “bbb” (Good) on subordinated debt
— “bbb-” (Good) on preferred stock

This press release relates to Credit Ratings that have been published on AM Best’s website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Best’s Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments.

AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2023 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.

Brent DeAngelis

Financial Analyst


+1 908 882 1730

brent.deangelis@ambest.com

Jacqalene Lentz

Director

+1 908 882 2011

jacqalene.lentz@ambest.com

Christopher Sharkey

Associate Director, Public Relations

+1 908 882 2310

christopher.sharkey@ambest.com

Al Slavin

Senior Public Relations Specialist

+1 908 882 2318

al.slavin@ambest.com

Source: AM Best

Globe Life Inc.

NYSE:GL

GL Rankings

GL Latest News

GL Stock Data

9.29B
81.90M
2.42%
84.3%
2.35%
Insurance - Life
Life Insurance
Link
United States of America
MCKINNEY